Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Vaginal Gel for Recurrent Dysmenorrhea
NCT00651313Phase 2Completed
- Sponsor
- Juniper Pharmaceuticals, Inc.
- Start
- Aug 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lidocaine 10% oropharyngeal spray in primary dysmenorrhea (PD), sponsored by Juniper Pharmaceuticals, Inc.. Started Aug 2007; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on NCT00651313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651313.